
$104.00
See if it's really the one
Search with this product to compare it, find similar styles, or turn up something better before deciding.
REPLENIX Redness Reducing Triple AOX Serum is a triple antioxidant powerhouse serum that is clinically proven to soothe skin and visibly reduce redness, pore size, and wrinkles while helping to minimize the harmful effects of free radicals. The lightly hydrating, oil-free formula is optimized for even the most sensitive skin types. How to Use After cleansing the skin, apply to the desired area once or twice a day or as directed by your doctor. Visibly reduce the appearance of redness, pore size, and wrinkles with REPLENIX Redness Reducing Triple AOX Serum. Key Ingredients Proprietary Green Tea Polyphenol Technology: Proven to be the most powerful and effective antioxidant - and now purified to its highest form with the most advanced proprietary delivery system - this powerhouse green tea technology works instantly to soothe and calm irritated skin while providing superior anti-aging protection from damaging free radicals. Resveratrol: This medical-grade ingredient has significant skin-calming properties to help minimize the look of redness while soothing skin and brightening the complexion. Caffeine USP: This clinical-grade, ultra-pure antioxidant enhances overall antioxidant activity to maximize protection against free radicals while helping to diminish the appearance of redness and irritation. Ingredients Purified Water, Sclerotium Gum, Caffeine U.S.P., Camellia Sinensis (Green Tea) Polyphenols, Sodium Hyaluronate, Resveratrol, Bisabolol, Cucumis Sativus (Cucumber) Fruit Extract, Chamomilla Recuitita (Matricaria) Flower Extract, Helianthus Annuus (Sunflower) Seed Oil, Rosmarinus Officinalis (Rosemary) Leaf Extract, Glycerin, Polysorbate-20, Sodium Benzoate, Tetrasodium EDTA, Phosphoric Acid, Phenoxyethanol
Have a question about this?
We currently ship within the US, with more countries coming soon.
Final cost and dates are confirmed at checkout.
🇺🇸 Ship from USA · On Agora since 2025
$104.00